GLP-1s are years ahead of any other potential breakthrough therapies for addiction treatment in the pipeline (with the partial exception of the new Vertex non-addictive painkiller, suzetrigine)
Currently, there is only two classes of drugs approved for the treatment of AD: N-methyl D -aspartate (NMDA) antagonist (memantine), and cholinesterase inhibitors (tacrine, Donepezil, galantamine, rivastigmine)
The injection delivers a calculated zinc dose, so additional intake may not be necessary
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist, a class of medication that mimics a natural hormone in the body to help regulate appetite and blood sugar
(E-G) Ratios of adipose tissue weight and body weight
But the underlying rationale isn't invented, which is a meaningful distinction from products that make claims without any mechanistic basis at all